GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (FRA:KOY) » Definitions » Change In Receivables

Kobayashi Pharmaceutical Co (FRA:KOY) Change In Receivables : €0 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Kobayashi Pharmaceutical Co Change In Receivables?

Kobayashi Pharmaceutical Co's change in receivables for the quarter that ended in Jun. 2024 was €0 Mil. It means Kobayashi Pharmaceutical Co's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

Kobayashi Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was €-24 Mil. It means Kobayashi Pharmaceutical Co's Accounts Receivable increased by €24 Mil from Dec. 2022 to Dec. 2023 .

Kobayashi Pharmaceutical Co's Accounts Receivable for the quarter that ended in Jun. 2024 was €207 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kobayashi Pharmaceutical Co's Days Sales Outstanding for the three months ended in Jun. 2024 was 87.54.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kobayashi Pharmaceutical Co's liquidation value for the three months ended in Jun. 2024 was €292 Mil.

Kobayashi Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Change In Receivables Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.76 12.58 -11.84 58.05 -24.08

Kobayashi Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kobayashi Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co  (FRA:KOY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kobayashi Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=206.909/215.69*91
=87.54

2. In Ben Graham's calculation of liquidation value, Kobayashi Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Kobayashi Pharmaceutical Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=355.24-309.084+0.75 * 206.909+0.5 * 181.427
=292

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (FRA:KOY) » Definitions » Change In Receivables
Comparable Companies
TSE:4912 TSE:4927 TSE:4922 TSE:8283 TSE:4921 TSE:7956 TSE:4928 TSE:4527 TSE:4919 TSE:4985 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
4967:Japan
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.kobayashi.co.jp
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co Headlines

No Headlines